2 144

Cited 0 times in

Comparison of the efficacy and toxicity between radiotherapy and chemotherapy in nodal and isolated nonnodal recurrence of ovarian cancer

Authors
 Maria Lee  ;  Sang Wun Kim  ;  San Hui Lee  ;  Jiheum Paek  ;  Ga Won Yim  ;  Gwi Eon Kim  ;  Sunghoon Kim  ;  Jae Hoon Kim  ;  Young Tae Kim  ;  Eun Ji Nam 
Citation
 International Journal of Gynecological Cancer, Vol.21(6) : 1032-1039, 2011 
Journal Title
 International Journal of Gynecological Cancer 
ISSN
 1048-891X 
Issue Date
2011
Abstract
OBJECTIVES: To assess and compare the efficacy and toxicity of radiotherapy (RT) versus chemotherapy (CT) in patients with nodal and isolated nonnodal recurrence of ovarian cancer. METHODS: Records of 67 patients treated for nodal or isolated nonnodal ovarian cancer recurrence (50 treated with RT and 17 treated with CT) between 2001 and 2010 were retrospectively reviewed. Patients' responses to RT and CT were assessed by the Response Evaluation Criteria in Solid Tumors, and toxicity was evaluated according to the National Cancer Institute Common Toxicity Criteria, version 3.0. Progression-free survival and overall survival were calculated using the Kaplan-Meier method. RESULTS: The overall response rate was 64.0% in the RT group and 16.7% in the CT group (P = 0.003). The median follow-up time was 38 months (range, 3-97 months) for RT and 18 months (range, 70-64 months) for CT. The median progression-free survival was 6 months for radiotherapy and 5 months for chemotherapy (P = 0.212). Median overall survival between the 2 groups was not significantly different (P = 0.246). There was no RT-mediated grade 3 or 4 hematologic toxicity, but overall toxicity was not significantly different between the 2 groups. CONCLUSIONS: Radiotherapy resulted in a better response and tolerable toxicities compared to CT in patients with either nodal or isolated nonnodal ovarian cancer recurrence. However, progression-free survival and overall survival did not differ between RT and CT. A prospective, multicenter, randomized controlled study is needed to evaluate the survival benefits of RT for ovarian cancer.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/93453
DOI
10.1097/IGC.0b013e31821e0353
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실)
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실)
Yonsei Authors
김귀언(Kim, Gwi Eon) ; 김상운(Kim, Sang Wun) ; 김성훈(Kim, Sung Hoon) ; 김영태(Kim, Young Tae) ; 김재훈(Kim, Jae Hoon) ; 남은지(Nam, Eun Ji) ; 백지흠(Paek, Ji Heum) ; 이마리아(Lee, Maria) ; 이산희(Lee, San Hui) ; 임가원(Yim, Ga Won)
사서에게 알리기
  feedback
Full Text
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00009577-201108000-00012&LSLINK=80&D=ovft
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse